Proximal fluid proteomics for the discovery of digestive cancer biomarkers

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1844, Issue 5, 2014, Pages 988-1002

  Farina, Annarita ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Ascites; Bile; Cyst fluid; Gastric juice; Pancreatic juice; Saliva

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A; COMPLEMENT COMPONENT C3; FIBRINOGEN; GASTRIN; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TRANSFERRIN; TUMOR MARKER;

ASCITES; BILE; BILIARY TRACT CANCER; CANCER DIAGNOSIS; CARCINOMATOSIS; CYSTIC NEOPLASM; DIGESTIVE SYSTEM CANCER; HUMAN; LIVER CANCER; MALIGNANT BILIARY TRACT STENOSIS; MOUTH CANCER; MOUTH LESION; NONHUMAN; PANCREAS CANCER; PANCREAS CYST; PANCREAS JUICE; PANCREATIC CYSTIC NEOPLASM; PERITONEUM CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; REVIEW; SALIVA; STOMACH CANCER; STOMACH JUICE; STOMACH LESION;

ASCITES; BILE; CYST FLUID; GASTRIC JUICE; PANCREATIC JUICE; SALIVA;

BODY FLUIDS; GASTROINTESTINAL NEOPLASMS; HUMANS; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898600280     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2013.10.011     Document Type: Review

References (157)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. American Cancer Society Cancer Facts & Figures 2013 2013 American Cancer Society Atlanta
3. M.A. Goldfarb, and T. Baker An eight-year analysis of surgical morbidity and mortality: data and solutions Am. Surg. 72 2006 1070 1081 (discussion 1126-1048) (Pubitemid 351837934)
4. K. Iwamura Capsule formation in hepatocellular carcinomas arising from liver cirrhosis Leber Magen Darm 18 1988 56 60
5. Y.S. Guan, Y. Hu, and Y. Liu Multidetector-row computed tomography in the management of hepatocellular carcinoma with transcatheter arterial chemoembolization J. Gastroenterol. Hepatol. 21 2006 941 946 (Pubitemid 43823276)
6. C. Bartolozzi, L. Crocetti, and M.C. Della Pina How to differentiate liver lesions in cirrhosis JBR-BTR 90 2007 475 481 (Pubitemid 351302437)
7. N.C. Yu, V. Chaudhari, S.S. Raman, C. Lassman, M.J. Tong, R.W. Busuttil, and D.S.K. Lu CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis Clin. Gastroenterol. Hepatol. 9 2011 161 167
8. G. Bertino, A. Ardiri, M. Malaguarnera, G. Malaguarnera, N. Bertino, and G.S. Calvagno Hepatocellualar carcinoma serum markers Semin. Oncol. 39 2012 410 433
9. R. Masuzaki, S.J. Karp, and M. Omata New serum markers of hepatocellular carcinoma Semin. Oncol. 39 2012 434 439
10. Use of tumor markers in liver, bladder, cervical, and gastric cancers The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines vol. 2013 2010 American Association for Clinical Chemistry
11. American Cancer Society Cancer Facts & Figures 2012 2012 American Cancer Society Atlanta
12. S. Cascinu, M. Falconi, V. Valentini, and S. Jelic Pancreatic cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann. Oncol. 21 Suppl. 5 2010 v55 v58
13. O.P. Zakharova, G.G. Karmazanovsky, and V.I. Egorov Pancreatic adenocarcinoma: outstanding problems World J. Gastrointest. Surg. 4 2012 104 113
14. J.M. Dumonceau, M. Polkowski, A. Larghi, P. Vilmann, M. Giovannini, J.L. Frossard, D. Heresbach, B. Pujol, G. Fernandez-Esparrach, E. Vazquez-Sequeiros, and A. Gines Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline Endoscopy 43 2011 897 912
15. J.M. Dumonceau, T. Koessler, J.E. van Hooft, and P. Fockens Endoscopic ultrasonography-guided fine needle aspiration: relatively low sensitivity in the endosonographer population World J. Gastroenterol. 18 2012 2357 2363
16. U.K. Ballehaninna, and R.S. Chamberlain The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal J. Gastrointest. Oncol. 3 2012 105 119
17. M.M. Bedi, M.D. Gandhi, G. Jacob, V. Lekha, A. Venugopal, and H. Ramesh CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit? Indian J. Gastroenterol. 28 2009 24 27
18. J.C. Box, and H.O. Douglas Management of cystic neoplasms of the pancreas Am. Surg. 66 2000 495 501 (Pubitemid 30252484)
19. G.F. Hutchins, and P.V. Draganov Cystic neoplasms of the pancreas: a diagnostic challenge World J. Gastroenterol. 15 2009 48 54
20. R.S. Kwon, and D.M. Simeone The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas Int. J. Proteomics 2011 2011 413646
21. O.A. Catalano, D.V. Sahani, S.P. Kalva, M.S. Cushing, P.F. Hahn, J.J. Brown, and R.R. Edelman MR imaging of the gallbladder: a pictorial essay Radiographics 28 2008 135 155 (quiz 324)
22. E.C. Lazcano-Ponce, J.F. Miquel, N. Munoz, R. Herrero, C. Ferrecio, I.I. Wistuba, P. Alonso de Ruiz, G. Aristi Urista, and F. Nervi Epidemiology and molecular pathology of gallbladder cancer CA Cancer J. Clin. 51 2001 349 364 (Pubitemid 34232782)
23. S.A. Khan, H.C. Thomas, B.R. Davidson, and S.D. Taylor-Robinson Cholangiocarcinoma Lancet 366 2005 1303 1314 (Pubitemid 41416587)
24. F. Mihalache, M. Tantau, B. Diaconu, and M. Acalovschi Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period J. Gastrointestin. Liver Dis. 19 2010 285 290
25. L.X. Qin, and Z.Y. Tang Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis World J. Gastroenterol. 9 2003 385 391
26. G.C. Vitale, M. George, K. McIntyre, G.M. Larson, and T.J. Wieman Endoscopic management of benign and malignant biliary strictures Am. J. Surg. 171 1996 553 557 (Pubitemid 26239291)
27. R. Gupta, G.V. Rao, and D.N. Reddy Benign biliary stricture - should they be dilated or treated surgically? Indian J. Gastroenterol. 25 2006 202 205 (Pubitemid 44413351)
28. J.M. Dumonceau, C. Macias Gomez, C. Casco, M. Genevay, M. Marcolongo, M. Bongiovanni, P. Morel, P. Majno, and A. Hadengue Grasp or brush for biliary sampling at endoscopic retrograde cholangiography? A blinded randomized controlled trial Am. J. Gastroenterol. 103 2008 333 340 (Pubitemid 351248706)
29. K. Inui, J. Yoshino, and H. Miyoshi Differential diagnosis and treatment of biliary strictures Clin. Gastroenterol. Hepatol. 7 2009 S79 S83
30. P. Charatcharoenwitthaya, F.B. Enders, K.C. Halling, and K.D. Lindor Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis Hepatology 48 2008 1106 1117
31. J.G. Hall, and T.N. Pappas Current management of biliary strictures J. Gastrointest. Surg. 8 2004 1098 1110 (Pubitemid 39600655)
32. J. Hyman, S.P. Wilczynski, and R.E. Schwarz Extrahepatic bile duct stricture and elevated CA 19-9: malignant or benign? South. Med. J. 96 2003 89 92 (Pubitemid 36207396)
33. VV.AA. Management of Gastric Cancer 2011 Intech Rijeka, Croatia
34. C.Y. Chen, Y.T. Kuo, C.H. Lee, T.J. Hsieh, C.M. Jan, T.S. Jaw, W.T. Huang, and F.J. Yu Differentiation between malignant and benign gastric ulcers: CT virtual gastroscopy versus optical gastroendoscopy Radiology 252 2009 410 417
35. C.Y. Chen, T.S. Jaw, Y.T. Kuo, J.S. Hsu, and G.C. Liu Differentiation of gastric ulcers with MDCT Abdom. Imaging 32 2007 688 693
36. R. Lomba-Viana, M. Dinis-Ribeiro, F. Fonseca, A.S. Vieira, M.J. Bento, and H. Lomba-Viana Serum pepsinogen test for early detection of gastric cancer in a European country Eur. J. Gastroenterol. Hepatol. 24 2012 37 41
37. P.D. McLaughlin, A. Filippone, and M.M. Maher Neoplastic diseases of the peritoneum and mesentery AJR Am. J. Roentgenol. 200 2013 W420 W430
38. C. Pfannenberg, N.F. Schwenzer, and B.L. Bruecher State-of-the-art imaging of peritoneal carcinomatosis Rofo 184 2012 205 213
39. M. Haslinger, V. Francescutti, K. Attwood, J.A. McCart, M. Fakih, J.M. Kane III, and J.J. Skitzki A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion Cancer Med. 2 2013 334 342
40. K.I. Votanopoulos, N.A. Newman, G. Russell, C. Ihemelandu, P. Shen, J.H. Stewart, and E.A. Levine Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality Ann. Surg. Oncol. 20 2013 3497 3503
41. K.I. Votanopoulos, K. Swett, A.U. Blackham, C. Ihemelandu, P. Shen, J.H. Stewart, and E.A. Levine Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer Ann. Surg. Oncol. 20 2013 1088 1092
42. R.O.S. Karoo, T.D.R. Lloyd, G. Garcea, H.D. Redway, and G.S.R. Robertson How valuable is ascitic cytology in the detection and management of malignancy? Postgrad. Med. J. 79 2003 292 294 (Pubitemid 36724241)
43. R. Jha, H.G. Shrestha, G. Sayami, and S.B. Pradhan Study of effusion cytology in patients with simultaneous malignancy and ascites Kathmandu Univ. Med. J. (KUMJ) 4 2006 483 487 (Pubitemid 351507106)
44. S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer Oral Oncol. 45 2009 309 316
45. B.W. Neville, and T.A. Day Oral cancer and precancerous lesions CA Cancer J. Clin. 52 2002 195 215
46. D. Kademani Oral cancer Mayo Clin. Proc. 82 2007 878 887 (Pubitemid 47015470)
47. VV.AA. Oral Cancer 2012 Intech Rijeka, Croatia
48. R.M. Logan, and A.N. Goss Biopsy of the oral mucosa and use of histopathology services Aust. Dent. J. 55 Suppl. 1 2010 9 13
49. Sample Preparation in Biological Mass Spectrometry 1st ed. 2011 Springer New York
50. A.L. D'Souza, J.R. Tseng, K.B. Pauly, S. Guccione, J. Rosenberg, S.S. Gambhir, and G.M. Glazer A strategy for blood biomarker amplification and localization using ultrasound Proc. Natl. Acad. Sci. U. S. A. 106 2009 17152 17157
51. N.L. Anderson, and N.G. Anderson The human plasma proteome: history, character, and diagnostic prospects Mol Cell Proteomics 1 2002 845 867
52. R. Schiess, B. Wollscheid, and R. Aebersold Targeted proteomic strategy for clinical biomarker discovery Mol. Oncol. 3 2009 33 44
53. A. Taguchi, and S.M. Hanash Unleashing the power of proteomics to develop blood-based cancer markers Clin. Chem. 59 2013 119 126
54. M. Fountoulakis, J.F. Juranville, L. Jiang, D. Avila, D. Roder, P. Jakob, P. Berndt, S. Evers, and H. Langen Depletion of the high-abundance plasma proteins Amino Acids 27 2004 249 259 (Pubitemid 40110065)
55. L. Urbas, P. Brne, B. Gabor, M. Barut, M. Strlic, T.C. Petric, and A. Strancar Depletion of high-abundance proteins from human plasma using a combination of an affinity and pseudo-affinity column J. Chromatogr. A 1216 2009 2689 2694
56. S. Surinova, R. Schiess, R. Huttenhain, F. Cerciello, B. Wollscheid, and R. Aebersold On the development of plasma protein biomarkers J. Proteome Res. 10 2011 5 16
57. Z. Cao, S. Yende, J.A. Kellum, and R.A. Robinson Additions to the human plasma proteome via a tandem MARS depletion iTRAQ-based workflow Int. J. Proteomics 2013 2013 654356
58. N.S. Barteneva, E. Fasler-Kan, M. Bernimoulin, J.N. Stern, E.D. Ponomarev, L. Duckett, and I.A. Vorobjev Circulating microparticles: square the circle BMC Cell Biol. 14 2013 23
59. T.H. Lee, E. D'Asti, N. Magnus, K. Al-Nedawi, B. Meehan, and J. Rak Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris' Semin. Immunopathol. 33 2011 455 467
60. P. O'Mullan, D. Craft, J. Yi, and C.A. Gelfand Thrombin induces broad spectrum proteolysis in human serum samples Clin. Chem. Lab. Med. 47 2009 685 693
61. P. O'Mullan, J. Yi, N. Sengupta, and C. Gelfand Intrinsic preanalytical variability of serum samples is evidenced in peptide MALDI MS spectra Mol. Cell. Proteomics 4 2005 S86-S86
62. P. Gromov, I. Gromova, C.J. Olsen, V. Timmermans-Wielenga, M.L. Talman, R.R. Serizawa, and J.M. Moreira Tumor interstitial fluid - a treasure trove of cancer biomarkers Biochim. Biophys. Acta 1834 2013 2259 2270
63. P.N. Teng, N.W. Bateman, B.L. Hood, and T.P. Conrads Advances in proximal fluid proteomics for disease biomarker discovery J. Proteome Res. 9 2010 6091 6100
64. P. McGing, and R. O'Kelley The biochemistry of body fluids 2009 ACBI Ireland
65. F.M. Amado, R.P. Ferreira, and R. Vitorino One decade of salivary proteomics: current approaches and outstanding challenges Clin. Biochem. 46 2013 506 517
66. V. Thongboonkerd Proteomics of Human Body Fluids 2007 Humana Press New Jersey, USA
67. M.P. Bard, J.P. Hegmans, A. Hemmes, T.M. Luider, R. Willemsen, L.A. Severijnen, J.P. van Meerbeeck, S.A. Burgers, H.C. Hoogsteden, and B.N. Lambrecht Proteomic analysis of exosomes isolated from human malignant pleural effusions Am. J. Respir. Cell Mol. Biol. 31 2004 114 121 (Pubitemid 38888047)
68. S. Runz, S. Keller, C. Rupp, A. Stoeck, Y. Issa, D. Koensgen, A. Mustea, J. Sehouli, G. Kristiansen, and P. Altevogt Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM Gynecol. Oncol. 107 2007 563 571 (Pubitemid 350160873)
69. M.A. Barbhuiya, N.A. Sahasrabuddhe, S.M. Pinto, B. Muthusamy, T.D. Singh, V. Nanjappa, S. Keerthikumar, B. Delanghe, H.C. Harsha, R. Chaerkady, V. Jalaj, S. Gupta, B.R. Shrivastav, P.K. Tiwari, and A. Pandey Comprehensive proteomic analysis of human bile Proteomics 11 2011 4443 4453
70. A. Farina, J.M. Dumonceau, and P. Lescuyer Proteomic analysis of human bile and potential applications for cancer diagnosis Expert Rev. Proteomics 6 2009 285 301
71. N. Lukic, R. Visentin, M. Delhaye, J.L. Frossard, P. Lescuyer, J.M. Dumonceau, and A. Farina An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis Biochim. Biophys. Acta 1844 2014 1027 1034 (this issue)
72. V.J. Patel, K. Thalassinos, S.E. Slade, J.B. Connolly, A. Crombie, J.C. Murrell, and J.H. Scrivens A comparison of labeling and label-free mass spectrometry-based proteomics approaches J. Proteome Res. 8 2009 3752 3759
73. P.-A. Clavien, and J. Baillie Diseases of the Gallbladder and Bile Ducts: Diagnosis and Treatment 2nd ed. 2006 Blackwell Pub. Malden, Mass.
74. A. Esteller Physiology of bile secretion World J. Gastroenterol. 14 2008 5641 5649
75. T.Z. Kristiansen, J. Bunkenborg, M. Gronborg, H. Molina, P.J. Thuluvath, P. Argani, M.G. Goggins, A. Maitra, and A. Pandey A proteomic analysis of human bile Mol. Cell. Proteomics 3 2004 715 728 (Pubitemid 39077002)
76. J. Koopmann, P.J. Thuluvath, M.L. Zahurak, T.Z. Kristiansen, A. Pandey, R. Schulick, P. Argani, M. Hidalgo, S. Iacobelli, M. Goggins, and A. Maitra Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma Cancer 101 2004 1609 1615 (Pubitemid 39318908)
77. N. Tinari, I. Kuwabara, M.E. Huflejt, P.F. Shen, S. Iacobelli, and F.T. Liu Glycoprotein 90 K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation Int. J. Cancer 91 2001 167 172 (Pubitemid 32041735)
78. C.Y. Chen, W.L. Tsai, H.C. Wu, M.J. Syu, C.C. Wu, and S.C. Shiesh Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis Clin. Chim. Acta 390 2008 82 89
79. A.A. Zabron, V.M. Horneffer-van der Sluis, C.A. Wadsworth, F. Laird, M. Gierula, A.V. Thillainayagam, P. Vlavianos, D. Westaby, S.D. Taylor-Robinson, R.J. Edwards, and S.A. Khan Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease Am. J. Gastroenterol. 106 2011 1711 1717
80. S. Chakraborty, S. Kaur, S. Guha, and S.K. Batra The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer Biochim. Biophys. Acta 1826 2012 129 169
81. T.O. Lankisch, J. Metzger, A.A. Negm, K. Vosskuhl, E. Schiffer, J. Siwy, T.J. Weismuller, A.S. Schneider, K. Thedieck, R. Baumeister, P. Zurbig, E.M. Weissinger, M.P. Manns, H. Mischak, and J. Wedemeyer Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis Hepatology 53 2011 875 884
82. J. Shen, W. Wang, J. Wu, B. Feng, W. Chen, M. Wang, J. Tang, F. Wang, F. Cheng, L. Pu, Q. Tang, X. Wang, and X. Li Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma PLoS One 7 2012 e47476
83. A. Farina, J.M. Dumonceau, P. Antinori, I. Annessi-Ramseyer, J.L. Frossard, D.F. Hochstrasser, M. Delhaye, and P. Lescuyer Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses Biochim. Biophys. Acta 1844 2014 1019 1026 (this issue)
84. T.M. Cheng, Y.M. Murad, C.C. Chang, M.C. Yang, T.N. Baral, A. Cowan, S.H. Tseng, A. Wong, R. Mackenzie, D.B. Shieh, and J. Zhang Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells Eur. J. Cancer 2012 (this issue)
85. L. Reinhard, C. Rupp, H.D. Riedel, T. Ruppert, T. Giese, C. Flechtenmacher, K.H. Weiss, P. Kloeters-Plachky, W. Stremmel, P. Schirmacher, P. Sauer, and D.N. Gotthardt S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis PLoS One 7 2012 e29821
86. W. Wang, K.X. Ai, Z. Yuan, X.Y. Huang, and H.Z. Zhang Different expression of S100A8 in malignant and benign gallbladder diseases Dig. Dis. Sci. 58 2013 150 162
87. S.G. Farid, R.A. Craven, J. Peng, G.K. Bonney, D.N. Perkins, P.J. Selby, K. Rajendra Prasad, and R.E. Banks Shotgun proteomics of human bile in hilar cholangiocarcinoma Proteomics 11 2011 2134 2138
88. A. Farina, J.M. Dumonceau, M. Delhaye, J.L. Frossard, A. Hadengue, D.F. Hochstrasser, and P. Lescuyer A step further in the analysis of human bile proteome J. Proteome Res. 10 2011 2047 2063
89. A. Farina, J.M. Dumonceau, J.L. Frossard, A. Hadengue, D.F. Hochstrasser, and P. Lescuyer Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer J. Proteome Res. 8 2009 159 169
90. M.E. Smith, and D.G. Morton The Digestive System 2001 Churchill Livingstone Edinburgh; New York
91. R. Chen, S. Pan, E.C. Yi, S. Donohoe, M.P. Bronner, J.D. Potter, D.R. Goodlett, R. Aebersold, and T.A. Brentnall Quantitative proteomic profiling of pancreatic cancer juice Proteomics 6 2006 3871 3879 (Pubitemid 44065164)
92. R. Chen, S. Pan, K. Cooke, K.W. Moyes, M.P. Bronner, D.R. Goodlett, R. Aebersold, and T.A. Brentnall Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis Pancreas 34 2007 70 79 (Pubitemid 46045723)
93. L. Zhou, Z. Lu, A. Yang, R. Deng, C. Mai, X. Sang, K.N. Faber, and X. Lu Comparative proteomic analysis of human pancreatic juice: methodological study Proteomics 7 2007 1345 1355 (Pubitemid 46716055)
94. M. Tian, Y.Z. Cui, G.H. Song, M.J. Zong, X.Y. Zhou, Y. Chen, and J.X. Han Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients BMC Cancer 8 2008 241
95. B. Sitek, B. Sipos, I. Alkatout, G. Poschmann, C. Stephan, T. Schulenborg, K. Marcus, J. Luttges, D.D. Dittert, G. Baretton, W. Schmiegel, S.A. Hahn, G. Kloppel, H.E. Meyer, and K. Stuhler Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation J. Proteome Res. 8 2009 1647 1656
96. J. Gao, F. Zhu, S. Lv, Z. Li, Z. Ling, Y. Gong, C. Jie, and L. Ma Identification of pancreatic juice proteins as biomarkers of pancreatic cancer Oncol. Rep. 23 2010 1683 1692
97. S. Lv, J. Gao, F. Zhu, Z. Li, Y. Gong, G. Xu, and L. Ma Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets Diagn. Cytopathol. 39 2011 875 881
98. Y. Shirai, K. Sogawa, T. Yamaguchi, K. Sudo, A. Nakagawa, Y. Sakai, T. Ishihara, M. Sunaga, M. Nezu, T. Tomonaga, M. Miyazaki, H. Saisho, and F. Nomura Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas Hepatogastroenterology 55 2008 1824 1829
99. T. Marchbank, A. Mahmood, and R.J. Playford Pancreatic secretory trypsin inhibitor causes autocrine-mediated migration and invasion in bladder cancer and phosphorylates the EGF receptor, Akt2 and Akt3, and ERK1 and ERK2 Am. J. Physiol. Renal Physiol. 305 2013 F382 F389
100. R. Chen, S. Pan, X. Duan, B.H. Nelson, R.A. Sahota, S. de Rham, R.A. Kozarek, M. McIntosh, and T.A. Brentnall Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia Mol. Cancer 9 2010 149
101. K.E. Vanderlaag, S. Hudak, L. Bald, L. Fayadat-Dilman, M. Sathe, J. Grein, and M.J. Janatpour Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin Breast Cancer Res. 12 2010 R32
102. P. Patel, C. Clarke, D.L. Barraclough, T.A. Jowitt, P.S. Rudland, R. Barraclough, and L.Y. Lian Metastasis-promoting anterior gradient 2 protein has a dimeric thioredoxin fold structure and a role in cell adhesion J. Mol. Biol. 425 2013 929 943
103. J.Y. Park, S.A. Kim, J.W. Chung, S. Bang, S.W. Park, Y.K. Paik, and S.Y. Song Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer J. Cancer Res. Clin. Oncol. 137 2011 1229 1238
104. S. Makawita, C. Smith, I. Batruch, Y. Zheng, F. Ruckert, R. Grutzmann, C. Pilarsky, S. Gallinger, and E.P. Diamandis Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers Mol. Cell. Proteomics 10 2011 (M111 008599)
105. E. Ke, B.B. Patel, T. Liu, X.M. Li, O. Haluszka, J.P. Hoffman, H. Ehya, N.A. Young, J.C. Watson, D.S. Weinberg, M.T. Nguyen, S.J. Cohen, N.J. Meropol, S. Litwin, J.L. Tokar, and A.T. Yeung Proteomic analyses of pancreatic cyst fluids Pancreas 38 2009 e33 e42
106. C.J. Scarlett, J.S. Samra, A. Xue, R.C. Baxter, and R.C. Smith Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry ANZ J. Surg. 77 2007 648 653 (Pubitemid 47063352)
107. A. Cuoghi, A. Farina, K. Z'Graggen, J.M. Dumonceau, A. Tomasi, D.F. Hochstrasser, M. Genevay, P. Lescuyer, and J.L. Frossard Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts J. Proteome Res. 10 2011 2664 2670
108. B.F. Mann, J.A. Goetz, M.G. House, C.M. Schmidt, and M.V. Novotny Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins Mol. Cell. Proteomics 11 2012 (M111 015792)
109. R. Greger, and U. Windhorst Comprehensive Human Physiology: From Cellular Mechanisms to Integration vol. (2527) 1996 Springer-Verlag New York 2
110. T.C. Martinsen, K. Bergh, and H.L. Waldum Gastric juice: a barrier against infectious diseases Basic Clin. Pharmacol. Toxicol. 96 2005 94 102 (Pubitemid 40320612)
111. J. Ochei, and A. Kolhatkar Medical Laboratory Science: Theory and Practice 2000 Tata McGrow-Hill
112. W. Wu, and M.C. Chung The gastric fluid proteome as a potential source of gastric cancer biomarkers J. Proteomics 90 2013 3 13
113. K. Lee, M. Kye, J.S. Jang, O.J. Lee, T. Kim, and D. Lim Proteomic analysis revealed a strong association of a high level of alpha1-antitrypsin in gastric juice with gastric cancer Proteomics 4 2004 3343 3352 (Pubitemid 39525282)
114. P.I. Hsu, C.H. Chen, C.S. Hsieh, W.C. Chang, K.H. Lai, G.H. Lo, P.N. Hsu, F.W. Tsay, Y.S. Chen, M. Hsiao, H.C. Chen, and P.J. Lu Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer Clin. Cancer Res. 13 2007 876 883 (Pubitemid 46340362)
115. P.I. Hsu, C.H. Chen, M. Hsiao, D.C. Wu, C.Y. Lin, K.H. Lai, and P.J. Lu Diagnosis of gastric malignancy using gastric juice alpha1-antitrypsin Cancer Epidemiol. Biomarkers Prev. 19 2010 405 411
116. S.M. Ganji, F.R. Jazii, and A. Sahebghadam-Lotfi Structural features, biological functions of the alpha-1 antitrypsin and contribution to esophageal cancer X. Li, Squamous Cell Carcinoma 2012 InTech
117. Y.H. Chang, S.H. Lee, I.C. Liao, S.H. Huang, H.C. Cheng, and P.C. Liao Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells Mol. Cell. Proteomics 11 2012 1320 1339
118. W.C. Chang, P.I. Hsu, Y.Y. Chen, M. Hsiao, P.J. Lu, and C.H. Chen Observation of peptide differences between cancer and control in gastric juice Proteomics Clin. Appl. 2 2008 55 62 (Pubitemid 351210916)
119. O.L. Kon, T.T. Yip, M.F. Ho, W.H. Chan, W.K. Wong, S.Y. Tan, W.H. Ng, S.Y. Kam, A. Eng, P. Ho, R. Viner, H.S. Ong, and M.P. Kumarasinghe The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile BMC Med. Genomics 1 2008 54
120. W. Wu, W.C. Juan, C.R. Liang, K.G. Yeoh, J. So, and M.C. Chung S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis Proteomics Clin. Appl. 6 2012 152 162
121. C. Gebhardt, J. Nemeth, P. Angel, and J. Hess S100A8 and S100A9 in inflammation and cancer Biochem. Pharmacol. 72 2006 1622 1631 (Pubitemid 44666730)
122. E. Kipps, D.S. Tan, and S.B. Kaye Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research Nat. Rev. Cancer 13 2013 273 282
123. S.L. Sangisetty, and T.J. Miner Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures World J. Gastrointest. Surg. 4 2012 87 95
124. L. Gortzak-Uzan, A. Ignatchenko, A.I. Evangelou, M. Agochiya, K.A. Brown, P. St Onge, I. Kireeva, G. Schmitt-Ulms, T.J. Brown, J. Murphy, B. Rosen, P. Shaw, I. Jurisica, and T. Kislinger A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers J. Proteome Res. 7 2008 339 351 (Pubitemid 351171148)
125. C. Kuk, V. Kulasingam, C.G. Gunawardana, C.R. Smith, I. Batruch, and E.P. Diamandis Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers Mol. Cell. Proteomics 8 2009 661 669
126. S. Elschenbroich, V. Ignatchenko, B. Clarke, S.E. Kalloger, P.C. Boutros, A.O. Gramolini, P. Shaw, I. Jurisica, and T. Kislinger In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry J. Proteome Res. 10 2011 2286 2299
127. G. Hariprasad, R. Hariprasad, L. Kumar, A. Srinivasan, S. Kola, and A. Kaushik Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers Biomarkers 18 2013 532 541
128. D.S. Choi, J.O. Park, S.C. Jang, Y.J. Yoon, J.W. Jung, D.Y. Choi, J.W. Kim, J.S. Kang, J. Park, D. Hwang, K.H. Lee, S.H. Park, Y.K. Kim, D.M. Desiderio, K.P. Kim, and Y.S. Gho Proteomic analysis of microvesicles derived from human colorectal cancer ascites Proteomics 11 2011 2745 2751
129. H. Kosanam, S. Makawita, B. Judd, A. Newman, and E.P. Diamandis Mining the malignant ascites proteome for pancreatic cancer biomarkers Proteomics 11 2011 4551 4558
130. M. Greabu, M. Battino, M. Mohora, A. Totan, A. Didilescu, T. Spinu, C. Totan, D. Miricescu, and R. Radulescu Saliva - a diagnostic window to the body, both in health and in disease J. Med. Life 2 2009 124 132
131. V. de Almeida Pdel, A.M. Gregio, M.A. Machado, A.A. de Lima, and L.R. Azevedo Saliva composition and functions: a comprehensive review J. Contemp. Dent. Pract. 9 2008 72 80
132. S. Chiappin, G. Antonelli, R. Gatti, and E.F. De Palo Saliva specimen: a new laboratory tool for diagnostic and basic investigation Clin. Chim. Acta 383 2007 30 40 (Pubitemid 47016442)
133. S. Bandhakavi, M.D. Stone, G. Onsongo, S.K. Van Riper, and T.J. Griffin A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva J. Proteome Res. 8 2009 5590 5600
134. S. Hu, M. Arellano, P. Boontheung, J. Wang, H. Zhou, J. Jiang, D. Elashoff, R. Wei, J.A. Loo, and D.T. Wong Salivary proteomics for oral cancer biomarker discovery Clin. Cancer Res. 14 2008 6246 6252
135. T.D. Oberley, and L.W. Oberley Antioxidant enzyme levels in cancer Histol. Histopathol. 12 1997 525 535 (Pubitemid 27240324)
136. Z. Ding, and P. Roy Profilin-1 versus profilin-2: two faces of the same coin? Breast Cancer Res. 15 2013 311
137. Y.J. Jou, C.D. Lin, C.H. Lai, C.H. Chen, J.Y. Kao, S.Y. Chen, M.H. Tsai, S.H. Huang, and C.W. Lin Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer Anal. Chim. Acta. 681 2010 41 48
138. E.P. de Jong, H. Xie, G. Onsongo, M.D. Stone, X.B. Chen, J.A. Kooren, E.W. Refsland, R.J. Griffin, F.G. Ondrey, B. Wu, C.T. Le, N.L. Rhodus, J.V. Carlis, and T.J. Griffin Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions PLoS One 5 2010 e11148
139. H. He, G. Sun, F. Ping, and Y. Cong A new and preliminary three-dimensional perspective: proteomes of optimization between OSCC and OLK Artif. Cells Blood Substit. Immobil. Biotechnol. 39 2011 26 30
140. Y.J. Jou, C.D. Lin, C.H. Lai, C.H. Tang, S.H. Huang, M.H. Tsai, S.Y. Chen, J.Y. Kao, and C.W. Lin Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages Clin. Chim. Acta 412 2011 1357 1365
141. O. Brinkmann, D.A. Kastratovic, M.V. Dimitrijevic, V.S. Konstantinovic, D.B. Jelovac, J. Antic, V.S. Nesic, S.Z. Markovic, Z.R. Martinovic, D. Akin, N. Spielmann, H. Zhou, and D.T. Wong Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population Oral Oncol. 47 2011 51 55
142. T. Jarai, G. Maasz, A. Burian, A. Bona, E. Jambor, I. Gerlinger, and L. Mark Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma Pathol. Oncol. Res. 18 2012 623 628
143. A. Zhang, H. Sun, P. Wang, and X. Wang Salivary proteomics in biomedical research Clin. Chim. Acta 415 2013 261 265
144. J.Y. Wu, C. Yi, H.R. Chung, D.J. Wang, W.C. Chang, S.Y. Lee, C.T. Lin, Y.C. Yang, and W.C. Yang Potential biomarkers in saliva for oral squamous cell carcinoma Oral Oncol. 46 2010 226 231
145. N. Spielmann, and D.T. Wong Saliva: diagnostics and therapeutic perspectives Oral Dis. 17 2011 345 354
146. M.E. Arellano-Garcia, R. Li, X. Liu, Y. Xie, X. Yan, J.A. Loo, and S. Hu Identification of tetranectin as a potential biomarker for metastatic oral cancer Int. J. Mol. Sci. 11 2010 3106 3121
147. S. Shintani, H. Hamakawa, Y. Ueyama, M. Hatori, and T. Toyoshima Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform Int. J. Oral Maxillofac. Surg. 39 2010 68 74
148. A.M. Contucci, R. Inzitari, S. Agostino, A. Vitali, A. Fiorita, T. Cabras, E. Scarano, and I. Messana Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report Oral Dis. 11 2005 95 99 (Pubitemid 40445117)
149. A. Vidotto, T. Henrique, L.S. Raposo, J.V. Maniglia, and E.H. Tajara Salivary and serum proteomics in head and neck carcinomas: before and after surgery and radiotherapy Cancer Biomark. 8 2010 95 107
150. Z.Z. Wu, J.G. Wang, and X.L. Zhang Diagnostic model of saliva protein finger print analysis of patients with gastric cancer World J. Gastroenterol. 15 2009 865 870
151. H. Xiao, L. Zhang, H. Zhou, J.M. Lee, E.B. Garon, and D.T. Wong Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry Mol. Cell. Proteomics 11 2012 (M111 012112)
152. L. Zhang, H. Xiao, S. Karlan, H. Zhou, J. Gross, D. Elashoff, D. Akin, X. Yan, D. Chia, B. Karlan, and D.T. Wong Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer PLoS One 5 2010 e15573
153. E.P. Diamandis Cancer biomarkers: can we turn recent failures into success? J. Natl. Cancer Inst. 102 2010 1462 1467
154. E. Drucker, and K. Krapfenbauer Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine EPMA J. 4 2013 7
155. G. Poste Bring on the biomarkers Nature 469 2011 156 157
156. E.P. Diamandis The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem? BMC Med. 10 2012 87
157. D.A. Morrow, and J.A. de Lemos Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952 (Pubitemid 46328287)